质母细胞瘤的动态髓质蛋白丰富的微环境:对免疫疗法疗效的重大挑战
Cindy Lamorlette1, Cédric Boura2, Sophie Pinel2
1Université de Lorraine, Centre National de Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7365 Ingénierie Moléculaire, Cellulaire et Physiopathologie (IMoPA), Nancy, France.
Frontiers in immunology
|February 26, 2026
概括
质母细胞瘤 (GBM) 治疗由于瘤微环境 (TME) 而扎. 了解TME因素对于开发有效的免疫疗法来治疗这种侵袭性脑癌至关重要.
科学领域:
- 神经瘤学神经瘤学
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种具有有限治疗疗效的侵袭性成人脑瘤.
- 免疫疗法是有前途的,但受到GBM瘤微环境 (TME) 的阻碍.
- 诸如瘤遗传学和先前的治疗等因素会影响TME.
研究的目的:
- 审查调节GBM TME的主要因素.
- 强调需要综合模型来研究GBM TME.
- 引导开发先进的,个性化的GBM免疫疗法.
主要方法:
- 关于GBM TME研究的文献综述.
- 分析影响TME组成和功能的因素.
- 讨论TME研究的建模方法.
主要成果:
- 在GBM TME中确定了关键的细胞和分子组件.
- 突出了瘤细胞与周围微观环境之间的复杂相互作用.
- 强调了传统治疗对TME特征的影响.
结论:
- GBM TME对有效的免疫疗法构成重大障碍.
- 开发复杂的模型对于理解TME动态至关重要.
- 准TME组件为改善GBM治疗策略提供了一条途径.
相关概念视频
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K


